<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CADL
Candel Therapeutics
$
()


  • Candel Therapeutics to present on CAN-3110, CAN-2409 at ASCO meeting

    Today - 08:18am
  • Three new option listings on April 15th

    4/15/2024 - 08:31am
  • Candel Therapeutics announces U.S. FDA granted ODD to CAN-2409

    4/11/2024 - 09:05am
  • Candel Therapeutics presents preclinical data on immunotherapy candidate

    4/9/2024 - 08:12am
  • Candel Therapeutics' treatment of pancreatic cancer receives orphan designation

    4/8/2024 - 18:04pm
  • Candel Therapeutics Inc trading resumes

    4/5/2024 - 09:41am
  • Candel Therapeutics Inc trading halted, volatility trading pause

    4/5/2024 - 09:36am
  • Candel Therapeutics announces interim data from Phase 2 trial of CAN-2409

    4/4/2024 - 08:27am
  • Candel Therapeutics presents updated data from Phase 1b trial of CAN-3110

    3/28/2024 - 16:16pm
  • Candel Therapeutics reports Q4 EPS (38c) vs (18c) last year

    3/28/2024 - 08:08am
  • Candel Therapeutics announces CAN-3110 received U.S. FDA FTD

    2/13/2024 - 07:32am
  • Candel Therapeutics provides update on upcoming milestones

    2/5/2024 - 08:15am
  • TScan Therapeutics appoints Amello as Chief Financial Officer

    1/29/2024 - 07:03am
  • Candel Therapeutics receives FDA fast track designation for CAN-2409

    12/12/2023 - 08:05am
  • Candel Therapeutics Inc trading resumes

    11/28/2023 - 09:50am
dynamic_feed Breaking News